Therefore, understanding the principal mechanisms underlying this injury would be extremely helpful for the development of effective therapeutic strategies that could substantially help cancer patients to take full efficacy of CP, meanwhile reducing the potential of AKI episodes. This evidence concerns the gene CP and acute kidney injury.